Drug or treatment

Cevostamab clinical trials

• 5Clinical trials
• 18Countries

Newest trials

All recruiting trials (5)

• Cevostamab with Pomalidomide and Dexamethasone after BCMA-directed CAR T therapy in multiple myeloma

  This study tests if Cevostamab combined with pomalidomide and dexamethasone can help people with multiple myeloma who have already had CAR T therapy and several prior treatments.

  Recruiting at 5 sites Phase 2 Hoffmann-La Roche · Nuremberg, Bavaria and 4 other locations · NCT07825064

• Cevostamab in systemic lupus erythematosus with or without active lupus nephritis

  This study tests cevostamab in people with systemic lupus erythematosus, with or without active lupus nephritis, to see how safe it is and how the body handles it when added to standard care.

  Recruiting at 11 sites Phase 1 Genentech, Inc. · Parkville, Victoria and 10 other locations · NCT07629583

• Cevostamab with pomalidomide and dexamethasone vs standard care in previously treated multiple myeloma

  This study tests whether adding cevostamab to pomalidomide and dexamethasone helps people with multiple myeloma who have already had some prior treatments and exposure to anti-CD38 therapy and lenalidomide.

  Recruiting at 103 sites Phase 3 Hoffmann-La Roche · Duarte, California and 102 other locations · NCT07555938

• Evaluating a new combination treatment for relapsed or refractory multiple myeloma

  This study is testing a new combination of two treatments for people with relapsed or refractory multiple myeloma to see if it's safe and how well it works.

  Recruiting at 14 sites Phase 1 Genentech, Inc. · Camperdown, New South Wales and 13 other locations · NCT05927571

• Cevostamab in relapsed or refractory multiple myeloma

  This early-stage trial tests cevostamab alone or with standard therapies to see if it is safe and how it behaves in people with relapsed or refractory multiple myeloma.

  Recruiting at 4 sites Phase 1 Genentech, Inc. · Duarte, California and 33 other locations · NCT04910568

Quick answers

How many clinical trials of Cevostamab are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 18 countries. The most sites are in Australia (4 trials), Israel (3 trials), South Korea (3 trials), France (3 trials), Italy (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →